Ling-Jian Zhang (Lingjian Zhang)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Cardiovascular Events

Lipopolysaccharide Induced

Top Venues

Phytotherapy research : PTR

BioMed research international

Journal of clinical and translational hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Ling-Jian Zhang, Yalei Zhao, Zhongyang Xie, Lanlan Xiao, Qingqing Hu, Qian Li, Shima Tang, Jie Wang, Lan-Juan Li
1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure. Journal of clinical and translational hepatology 10 (4) (2022)
Lan-Lan Xiao, Xiao-Wei Xu, Kai-Zhou Huang, Ya-Lei Zhao, Ling-Jian Zhang, Lan-Juan Li
Corrigendum to "Artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis". BioMed research international 2021 (2021)
Zhongyang Xie, Ling-Jian Zhang, Ermei Chen, Juan Lu, Lanlan Xiao, Qiuhong Liu, Danhua Zhu, Fen Zhang, Xiaowei Xu, Lanjuan Li
Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury. Metabolites 11 (12) (2021)
Ling-Jian Zhang, Yalei Zhao, Linxiao Fan, Kai Xu, Feiyang Ji, Zhongyang Xie, Xiaoxi Ouyang, Daxian Wu, Lan-Juan Li
Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/mitogen-activated protein kinase and TLR4/nuclear factor-κB pathways and autophagy. Phytotherapy research : PTR 33 (4) (2019)